secwatch.observer — SEC 8-K summary
======================================

Issuer:     Adicet Bio, Inc. (ACET)
CIK:        0001720580
Form:       8-K
Filed at:   2025-10-07T23:59:59+00:00
Accession:  0001193125-25-233427
Event type: other_material
Sentiment:  negative
Materiality: 0.55
Item codes: 3.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Adicet Bio granted 180-day Nasdaq extension; transferred to Capital Market
--------------------------------------------------------------------------

- Extension until April 6, 2026 to regain $1.00 minimum bid price; transferred to Nasdaq Capital Market effective Oct 9, 2025.
- Company may consider reverse stock split to meet bid price requirement; if not regained, Nasdaq will issue delisting notice.
- Previous 180-day compliance period ended Oct 6, 2025; extension granted Oct 7, 2025.
- No immediate impact on common stock listing; ACET continues trading under symbol ACET.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1720580/000119312525233427/0001193125-25-233427-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1720580/000119312525233427/acet-20251007.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-233427

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer